TransCelerate eyes GCP standard; Accelovance doubles down on cancer;

> TransCelerate BioPharma, a Justice League-like cadre of the world's largest drug developers, is working on a mutual recognition system to evaluate good clinical practices adherence for trial sites. Article

> CRO Accelovance is expanding its staff and clinical capabilities to focus on cancer R&D. News

> Canadian research outfit MannaResearch bought Kells Medical Research Group, a clinical investigator site. Story

> India is struggling to regulate its clinical research industry, balancing patient safety with its interest in maintaining what has become a huge economic contributor for the country. Live Mint weighs in on how the government should move forward. Opinion

> CRO SRI International has discovered a potential biomarker for Huntington's disease, looking at electrical activity in the brains of mouse models that could indicate the disease before major symptoms set in. Item

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.